Table 2.
Treatment, operative, and postoperative characteristics
| Characteristic | Data (n = 124) |
|---|---|
| Preoperative radiation | |
| No | 8 (6.5) |
| Long course chemoradiation | 84 (67.7) |
| Short course chemotherapy | 33 (26.6) |
| Preoperative chemotherapy | 66 (53.2) |
| Surgery | |
| Total pelvic exenteration | 74 (59.7) |
| Posterior exenteration | 36 (29.0) |
| Bladder sparing exenteration | 14 (11.3) |
| Surgical approach | |
| Laparoscopic | 95 (76.6) |
| Robotic | 29 (23.4) |
| Sphincter preservation | 36 (29.0) |
| Lateral pelvic node dissection | 70 (56.5) |
| Urinary reconstruction | |
| Ileal conduit | 72 (58.1) |
| Sigmoid conduit | 4 (3.2) |
| Supra-pubic catheter | 14 (11.3) |
| Ureteric reimplantation | 1 (0.8) |
| Not applicable | 47 (37.9) |
| Perineal reconstruction (n = 95) | 66 (69.5) |
| Sacrectomy | 5 (4.0) |
| Surgical duration (min) | 520 (420–650) |
| Blood loss (mL) | 700 (480–1,300) |
| Hospital stay (mL) | 11 (8–15) |
| Clavien-Dindo complications | |
| 0 | 48 (38.7) |
| I | 12 (9.7) |
| II | 29 (23.4) |
| IIIA | 14 (11.3) |
| IIIB | 17 (13.7) |
| IV | 1 (0.8) |
| V | 3 (2.4) |
| Complications, ASA PS grade ≥IIIA; 95% CI | 35 (28.2); 20.5%–37.0% |
| Leak | |
| Urinary (n = 91) | 13 (14.3) |
| Bowel (n = 36) | 5 (13.9) |
| Surgical site infection | 27 (21.8) |
| Small bowel obstruction | 13 (10.5) |
Values are presented as number (%) and median range unless otherwise specified.
ASA PS, American Society of Anesthesiologist physical status; CI, confidence interval.